In Germany, the alimentary tract and metabolism medicine sales as a percentage of total sales are projected to show a slight decline from 2024 to 2028. The forecast indicates a decrease from 10.1% in 2024 to 9.6% in 2028. The year-on-year variation suggests a steady regression, mirroring a consistent annual downward adjustment. The compound annual growth rate (CAGR) over this period reinforces the trend of a modest decline.
Future trends to watch for include:
- Potential impact of regulatory changes on healthcare and medicinal pricing.
- Technological advancements in alternative therapies possibly affecting sales.
- Economic factors influencing public healthcare spending and drug affordability.
